In vitro synergy studies with Clostridium difficile
Open Access
- 1 March 1991
- journal article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 35 (3) , 582-583
- https://doi.org/10.1128/aac.35.3.582
Abstract
Agar dilution anaerobic susceptibility studies using rifampin, vancomycin, metronidazole, and bacitracin individually and in combination were performed with Clostridium difficile. Fifty-five strains of C. difficile were studied. Eighty-five percent of strains tested (29 of 34) were synergistically inhibited by the combination of bacitracin and rifampin (fractional inhibitory concentration, less than or equal to 0.50).Keywords
This publication has 9 references indexed in Scilit:
- BACTERIOTHERAPY FOR CHRONIC RELAPSING CLOSTRIDIUM DIFFICILE DIARRHOEA IN SIX PATIENTSPublished by Elsevier ,1989
- Treatment of antibiotic-associated Clostridium difficile colitis with oral vancomycin: Comparison of two dosage regimensThe American Journal of Medicine, 1989
- Therapy of Relapsing Clostridium difficile Associated Diarrhea and Colitis with the Combination of Vancomycin and RifampinJournal of Clinical Gastroenterology, 1987
- Antibiotic-associated colitis due to Clostridium difficile: Double-blind comparison of vancomycin with bacitracinGastroenterology, 1985
- PROSPECTIVE RANDOMISED TRIAL OF METRONIDAZOLE VERSUS VANCOMYCIN FOR CLOSTRIDIUM-DIFFICILE-ASSOCIATED DIARRHOEA AND COLITISThe Lancet, 1983
- The fractional inhibitory concentration (FIC) index as a measure of synergyJournal of Antimicrobial Chemotherapy, 1983
- Treatment of Clostridium difficile colitis and diarrhea with vancomycinThe American Journal of Medicine, 1981
- Cytotoxicity Assay in Antibiotic-Associated ColitisThe Journal of Infectious Diseases, 1979
- ANTAGONISTS OF NUCLEIC ACID DERIVATIVES .8. SYNERGISM IN COMBINATIONS OF BIOCHEMICALLY RELATED ANTIMETABOLITES1954